Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-287065
Filing Date
2024-12-31
Accepted
2024-12-31 06:34:00
Documents
13
Period of Report
2024-12-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d905396d8ka.htm   iXBRL 8-K/A 24651
  Complete submission text file 0001193125-24-287065.txt   146952

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20241227.xsd EX-101.SCH 2545
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20241227_lab.xml EX-101.LAB 17911
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20241227_pre.xml EX-101.PRE 11246
15 EXTRACTED XBRL INSTANCE DOCUMENT d905396d8ka_htm.xml XML 4133
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39267 | Film No.: 241591149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)